The Global Medical Bioactive Glass Powder Market was valued at USD 448 Million in 2023 and is projected to reach USD 719.19 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.40% during the forecast period. North America Medical Bioactive Glass Powder market size was estimated at USD 127.79 million in 2023, at a CAGR of 4.63% during the forecast period of 2025 through 2032. This growth is being driven by rising demand for advanced biomaterials in orthopedics and dentistry, increasing prevalence of bone-related disorders, and accelerating adoption of regenerative solutions like 45S5 and S53P4 bioactive glass powders across surgical and wound care applications.
As the biomedical industry transforms toward regenerative therapies and tissue engineering, the spotlight is on the key material innovators who are driving biocompatibility, clinical efficacy, and next-generation healing pathways. In this blog, we profile the Top 10 Companies in the Medical Bioactive Glass Powder Industry—a mix of medtech giants, specialized biomaterial firms, and research pioneers shaping the future of global regenerative medicine.
🔟 1. Stryker Corporation
Headquarters: Kalamazoo, Michigan, USA
Key Offering: Bioactive glass powders for orthopedics, bone void fillers, and regenerative coatings
Stryker stands as a global leader in medical technology, with its orthopedics and spine divisions extensively utilizing bioactive glass powders to enhance bone regeneration and implant integration. The company’s portfolio includes advanced composites that leverage bioactive glass for faster healing in trauma and spinal fusion procedures, serving hospitals and surgeons worldwide through a robust distribution network.
Because of its focus on evidence-based innovation, Stryker integrates bioactive glass into products like its cementless implants, which promote osteoconduction and reduce recovery times. Furthermore, ongoing clinical studies demonstrate superior bone ingrowth compared to traditional materials, positioning the company at the forefront of minimally invasive surgeries.
Innovation Initiatives:
- Development of hybrid bioactive glass-ceramic composites for load-bearing applications
- Clinical partnerships for long-term implant performance trials
- Expansion of bioactive glass use in dental and maxillofacial reconstruction
Download FREE Sample Report: Medical Bioactive Glass Powder Market – View in Detailed Research Report
9️⃣ 2. SCHOTT AG
Headquarters: Mainz, Germany
Key Offering: High-purity bioactive glass powders, custom formulations for medical devices
SCHOTT, a premier glass technology specialist, excels in producing pharmaceutical and bioactive glass powders tailored for biomedical uses. Operating advanced manufacturing facilities across Europe and North America, the company supplies bioactive glass for coatings, scaffolds, and injectable pastes that bond directly with living bone and soft tissue.
The firm’s expertise in precise particle size control and composition optimization ensures consistent bioactivity, making its products ideal for demanding applications in orthopedics and dentistry. SCHOTT’s commitment to scalability supports growing demands from contract manufacturers and OEMs globally.
Innovation Initiatives:
- Antibacterial bioactive glass variants to combat implant infections
- Collaboration with research institutes on 3D-printed bioactive scaffolds
- Sustainable production processes reducing energy use in glass synthesis
8️⃣ 3. Synergy Biomedical
Headquarters: Madison, Alabama, USA
Key Offering: 45S5 bioactive glass powder (NovaBone), bone graft substitutes
Synergy Biomedical specializes in bioactive glass-based products, particularly its flagship 45S5 composition, which triggers rapid hydroxyapatite formation for bone repair. The company serves orthopedic surgeons with putty and foam formulations for filling bone defects in trauma, oncology, and spinal cases.
With FDA clearances and extensive clinical data backing its efficacy, Synergy’s powders demonstrate osteostimulation, promoting natural bone growth without synthetic growth factors. This positions it strongly in the shift toward resorbable biomaterials.
Innovation Initiatives:
- Next-gen bioactive glass with enhanced resorption rates
- Partnerships for combination therapies in chronic wound healing
- Clinical expansion into veterinary orthopedics
7️⃣ 4. BonAlive Biomaterials Ltd.
Headquarters: Turku, Finland
Key Offering: S53P4 bioactive glass powder, granules for chronic osteomyelitis treatment
BonAlive leads with its clinically proven S53P4 bioactive glass, approved in Europe and gaining U.S. traction for treating bone infections. The powder’s antibacterial properties eliminate biofilms while stimulating bone regeneration, reducing the need for antibiotics and secondary surgeries.
Backed by over a decade of peer-reviewed studies, BonAlive’s products are used in more than 20 countries, particularly for complex cases like diabetic foot ulcers and jaw reconstructions. Its focus on infection control addresses critical unmet needs in orthopedics.
Innovation Initiatives:
- Granule size optimization for better surgical handling
- Trials for soft tissue regeneration in cosmetics
- Global regulatory submissions for broader indications
Download FREE Sample Report: Medical Bioactive Glass Powder Market – View in Detailed Research Report
6️⃣ 5. Halma plc (NovaBone Products)
Headquarters: Amersham, United Kingdom
Key Offering: NovaBone bioactive glass powders for dental and orthopedic regeneration
Through its NovaBone brand, Halma provides bioactive glass solutions that mimic natural bone mineralization. These powders are integral to periodontal treatments and alveolar ridge preservation, helping dentists achieve predictable outcomes in implantology.
The company’s dental division emphasizes bioresorbable fillers that integrate seamlessly, supported by long-term clinical follow-ups showing high success rates. Halma’s global reach extends its impact in emerging markets seeking advanced biomaterials.
Innovation Initiatives:
- Bioactive glass microspheres for injectable bone cements
- Integration with stem cell therapies
- Expansion into cosmetic fillers for soft tissue augmentation
5️⃣ 6. Mo-Sci Corporation
Headquarters: Rolla, Missouri, USA
Key Offering: Custom bioactive glass powders, fibers for tissue engineering
Mo-Sci excels in tailoring bioactive glass compositions for research and commercial applications, including powders for wound dressings and scaffolds. Its versatile manufacturing capabilities support rapid prototyping and scale-up for medtech partners.
Known for its role in NIH-funded projects, Mo-Sci’s glasses promote angiogenesis and tissue infiltration. This makes them valuable for chronic wounds resistant to standard treatments, with applications expanding into veterinary medicine.
Innovation Initiatives:
- Doped bioactive glasses for controlled drug release
- Collaborations on electrospun bioactive glass mats
- Sustainable sourcing of raw materials for eco-friendly production
4️⃣ 7. Johnson & Johnson (DePuy Synthes)
Headquarters: New Brunswick, New Jersey, USA
Key Offering: Bioactive glass-enhanced implants, coatings for joint reconstruction
DePuy Synthes incorporates bioactive glass powders into its extensive orthopedics portfolio, enhancing implant longevity and osseointegration. Products like coated stems and cements benefit from the material’s ability to form strong tissue bonds.
With a strong emphasis on surgeon education and outcomes data, J&J drives adoption through large-scale registries. This approach solidifies its leadership in high-volume procedures like hip and knee replacements.
Innovation Initiatives:
- Bioactive glass for 3D-printed patient-specific implants
- Antimicrobial coatings to prevent peri-implantitis
- Global trials for accelerated recovery protocols
Download FREE Sample Report: Medical Bioactive Glass Powder Market – View in Detailed Research Report
3️⃣ 8. NORAKER
Headquarters: Saint Priest, France
Key Offering: P110 bioactive glass implants, powders for spinal and cranial repairs
NORAKER pioneers resorbable bioactive glass devices that fully convert to hydroxyapatite over time, eliminating foreign body reactions. Used in neurosurgery and spine, its powders support complex defect fillings with minimal inflammation.
Clinical results highlight faster fusion rates and reduced revision surgeries, appealing to European surgeons. NORAKER’s focus on total resorption differentiates it in a market shifting from permanent implants.
Innovation Initiatives:
- Custom bioactive glass for pediatric craniofacial surgery
- Partnerships for bioactive coatings on titanium alloys
- Expansion into Asia-Pacific markets
2️⃣ 9. Ferro Corporation
Headquarters: Mayfield Heights, Ohio, USA
Key Offering: Bioactive glass frits and powders for ceramic-medical hybrids
Ferro provides specialized bioactive glass powders for frits used in dental porcelains and bioactive ceramics. Its materials enable strong adhesion in restorative dentistry, supporting veneers, crowns, and bridges.
The company’s expertise in thermal processing ensures durability under oral conditions. Ferro’s innovations help meet rising demands for aesthetic and functional dental solutions in aging populations.
Innovation Initiatives:
- Nanostructured bioactive glasses for enhanced aesthetics
- Collaborations on bioactive glass-polymer composites
- R&D for orthodontic applications
1️⃣ 10. 3M Company
Headquarters: St. Paul, Minnesota, USA
Key Offering: Bioactive glass powders in wound care, dental composites, and orthopedics
3M leverages its materials science prowess to integrate bioactive glass into advanced dressings and restoratives that accelerate healing. Products like its glass-ionomer cements release ions for remineralization, widely used in global dentistry.
With unmatched R&D scale, 3M drives multi-application adoption, from chronic wounds to bone fillers. Its bioactive glasses enhance moisture balance and antimicrobial action, reducing infection risks.
However, 3M’s broad portfolio allows seamless integration across healthcare segments, ensuring market dominance through reliable supply and innovation pipelines.
Innovation Initiatives:
- Silver-doped bioactive glasses for superior antibiofilm activity
- Strategic alliances for regenerative skincare
- Mass production of 45S5 variants for cost-effective therapies
Read Full Report: Medical Bioactive Glass Powder Market – View in Detailed Research Report
🌍 Outlook: The Future of Medical Bioactive Glass Powder Is Regenerative and Precision-Driven
The Medical Bioactive Glass Powder market is undergoing a dynamic shift. While traditional bone grafts persist, the industry is investing heavily in advanced compositions, nanoparticle formulations, and combination therapies with stem cells and growth factors to enable precise tissue regeneration.
Because bioactive glasses offer unique bioactivity through rapid ion release and HCA layer formation, they are poised to dominate orthopedic, dental, and cosmetic segments. Furthermore, regulatory approvals and cost reductions will accelerate adoption in emerging economies, where chronic conditions drive demand.
📈 Key Trends Shaping the Market:
- Rapid expansion in orthopedics and dentistry applications across North America, Europe, and Asia-Pacific
- Regulatory advancements for new bioactive glass types like doped variants by 2030
- Digital integration with 3D printing and personalized medicine
- Strategic alliances between biomaterials firms and device manufacturers for hybrid solutions
Read Full Report: Medical Bioactive Glass Powder Market – View in Detailed Research Report
The companies listed above are not only powering medical regeneration—they’re spearheading the bioactive revolution in healing technologies.
- Top 10 Companies in the Global Marine Coatings for Leisure Boats Market (2025): Market Leaders in Anti-Fouling and Protective Solutions - April 26, 2026
- Top 10 Companies in the Global Crosslinked Polyethylene (PE-X) Pipe Industry (2026): Market Leaders Driving Efficient Plumbing Solutions - April 26, 2026
- Top 10 Companies in the Global Metallic Pearl Paint Market (2026): Market Leaders Delivering Shimmering Innovation Across Automotive and Architectural Sectors - April 26, 2026
